Advisory Services Network’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Advisory Services Network’s Portfolio BIB Stock Details BIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-671	Closed	-$35K	–	3086
2019 Q3	$35K	Hold	671	–	–	﹤0.01%	1538
2019 Q2	$35K	Sell	671 -65	-9%	-$3.23K	﹤0.01%	1536
2019 Q1	$41K	Sell	736 -17	-2%	-$916	﹤0.01%	1308
2018 Q4	$32K	Sell	753 -87	-10%	-$4.54K	﹤0.01%	1308
2018 Q3	$59K	Sell	840 -45	-5%	-$2.94K	﹤0.01%	1166
2018 Q2	$58K	Sell	885 -45	-5%	-$2.45K	﹤0.01%	1150
2018 Q1	$51K	Sell	930 -17	-2%	-$1.02K	﹤0.01%	1305
2017 Q4	$53K	Sell	947 -20	-2%	-$1.13K	﹤0.01%	1241
2017 Q3	$59K	Sell	967 -44	-4%	-$2.5K	0.01%	1037
2017 Q2	$54K	Sell	1,011 -69	-6%	-$3.37K	0.01%	1023
2017 Q1	$52K	Buy	+1,080	New	+$50.2K	0.01%	985
2016 Q3	$54K	Buy	1,123 +779	+226%	+$37K	0.01%	843
2016 Q2	$13K	Buy	+344	New	+$14.8K	﹤0.01%	1117

Other funds holding BIB

GWM

Geneos Wealth Management Englewood, Colorado $4.31B AUM 18.36% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

SBIA

Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return

SkyOak Wealth Southfield, Michigan $546M AUM 18.14% 1-Year Est. Return

CIA

Capital Investment Advisors Atlanta, Georgia $6.84B AUM 17.28% 1-Year Est. Return

Advisory Services Network's BIB Position: Q4 2019 in Review

Advisory Services Network sold out of ProShares Ultra NASDAQ Biotechnology (BIB) in Q4 2019, closing a stake of 671 shares — an estimated $35K sold.

Advisory Services Network first reported a position in BIB in Q2 2016 and held it in 13 quarters. The position peaked at $59K in Q3 2018. 26 funds tracked by Wall St. Rank hold BIB as of Q4 2019.

Advisory Services Network reported no remaining ProShares Ultra NASDAQ Biotechnology position as of Q4 2019 after selling out during the quarter.
Advisory Services Network sold 671 ProShares Ultra NASDAQ Biotechnology shares in Q4 2019, an estimated $35K.
Advisory Services Network first reported a position in ProShares Ultra NASDAQ Biotechnology in Q2 2016 and held it in 13 quarters.
Advisory Services Network's ProShares Ultra NASDAQ Biotechnology position peaked at $59K in Q3 2018.
26 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q4 2019.

Based on Advisory Services Network's 13F filing for Q4 2019, filed 4 Feb 2020.